GlassScriptPhysician profile
Eric Charles Schubert
NPI 1346439452
$3,250.86
in general payments reported to CMS, 2019-2025
46 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $254 · 2022: $279 · 2023: $2,425 · 2024: $50.68 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,717.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $287.90 | 2023 | Lumakras, Tavneos, Xgeva |
| Novartis Pharmaceuticals Corporation | $245.32 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $213.86 | 2023 | Opdivo, Opdualag |
| Celgene Corporation | $169.03 | 2022-2023 | Reblozyl, Opdualag |
| Merck Sharp & Dohme LLC | $162.74 | 2023 | Keytruda, Welireg, Lynparza |
| Takeda Pharmaceuticals U.S.A., INC. | $153.71 | 2022-2023 | Iclusig |
| Neurocrine Biosciences, INC. | $124.53 | 2021 | |
| Janssen Biotech, INC. | $122.23 | 2022-2023 | Darzalex, Tecvayli, Imbruvica |
| Boston Scientific Corporation | $121.76 | 2025 | Vercise |
| Medtronic, INC. | $120.09 | 2025 | Percept PC Brainsense |
| Biohaven Pharmaceuticals, INC. | $110.27 | 2021 | |
| Lilly USA, LLC | $109.31 | 2021-2023 | Verzenio, Olumiant, Taltz |
| Seagen INC. | $106.17 | 2023 | Adcetris, Padcev |
| Abbvie INC. | $100.21 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $91.16 | 2023 | Tagrisso, Imfinzi, Lynparza |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Schubert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.